RIPK4 and neoplasm: A recent study on tumor initiating cells showed that pSerSTAT3 promoted collagen17 expression resulting in enhanced tumor initiating capacity of these cells.46 Our in vitro analyses showed that STAT3 pathway activation promoted the expression of LOX, which was reverted upon overexpression of RIP4, WT or KD.